GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,404 | -99.7% | 1,856,194 | +147.5% | 0.36% | +335.4% |
| Q3 2022 | $1,928,000 | +6.2% | 750,000 | 0.0% | 0.08% | -15.5% |
| Q2 2022 | $1,815,000 | -41.3% | 750,000 | 0.0% | 0.10% | -24.8% |
| Q1 2022 | $3,090,000 | -68.0% | 750,000 | 0.0% | 0.13% | -50.8% |
| Q4 2021 | $9,645,000 | +346.7% | 750,000 | +200.0% | 0.26% | +201.1% |
| Q3 2019 | $2,159,000 | -61.2% | 250,000 | -50.0% | 0.09% | -61.3% |
| Q2 2019 | $5,570,000 | +109.4% | 500,000 | +150.0% | 0.22% | +106.4% |
| Q1 2019 | $2,660,000 | -13.9% | 200,000 | 0.0% | 0.11% | -4.4% |
| Q4 2018 | $3,090,000 | +8.5% | 200,000 | 0.0% | 0.11% | +54.1% |
| Q3 2018 | $2,848,000 | – | 200,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |